Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 1974.15 8.25 (0.42%) | NSE 1973.80 7.90 (0.40%) | Trade | Add

BSE Live

Dec 04, 16:01

1974.15 8.25 (0.42%)

Volume

AVERAGE VOLUME

5-Day

24,570

10-Day

25,882

30-Day

33,991

22,501

Prev. Close

1965.90
Open Price

1964.30

Bid Price (Qty.)
1970.00 (353)
Offer Price (Qty.)
1974.15 (1)

NSE Live

Dec 04, 15:58

1973.80 7.90 (0.40%)

Volume

AVERAGE VOLUME

5-Day

764,896

10-Day

932,215

30-Day

1,095,156

414,550

Prev. Close

1965.90
Open Price

1960.10

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1973.80 (1)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Glenmark Pharma (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
Per Share Ratios
Basic EPS (Rs.)	37.14	16.01	14.26	9.81	7.86
Diluted EPS (Rs.)	37.13	16.00	14.25	9.80	7.85
Cash EPS (Rs.)	41.54	17.11	15.18	10.59	8.63
Book Value [ExclRevalReserve]/Share (Rs.)	182.54	107.15	93.16	80.79	73.25
Book Value [InclRevalReserve]/Share (Rs.)	182.54	107.15	93.16	80.79	73.25
Dividend / Share(Rs.)	2.00	2.00	2.00	2.00	0.40
Revenue from Operations/Share (Rs.)	187.46	84.84	71.97	57.84	43.03
PBDIT/Share (Rs.)	57.13	20.76	16.57	13.53	13.23
PBIT/Share (Rs.)	52.73	19.65	15.64	12.75	12.45
PBT/Share (Rs.)	45.40	18.51	14.03	10.50	9.28
Net Profit/Share (Rs.)	37.14	16.00	14.26	9.81	7.85
Profitability Ratios
PBDIT Margin (%)	30.47	24.47	23.01	23.39	30.74
PBIT Margin (%)	28.12	23.16	21.73	22.04	28.93
PBT Margin (%)	24.21	21.81	19.49	18.15	21.56
Net Profit Margin (%)	19.81	18.85	19.80	16.95	18.24
Return on Networth / Equity (%)	20.34	14.92	15.30	12.13	10.71
Return on Capital Employed (%)	19.35	14.48	14.64	10.43	9.30
Return on Assets (%)	13.16	10.25	9.93	8.37	6.28
Total Debt/Equity (X)	0.07	0.12	0.12	0.22	0.54
Asset Turnover Ratio (%)	66.47	54.40	50.16	49.37	34.46
Liquidity Ratios
Current Ratio (X)	1.47	1.30	0.83	1.17	0.44
Quick Ratio (X)	1.17	1.13	0.68	0.89	0.30
Inventory Turnover Ratio (X)	6.90	10.93	10.25	8.89	7.41
Dividend Payout Ratio (NP) (%)	5.38	12.50	14.03	20.39	5.09
Dividend Payout Ratio (CP) (%)	4.81	11.69	13.17	18.89	4.63
Earnings Retention Ratio (%)	94.62	87.50	85.97	79.61	94.91
Cash Earnings Retention Ratio (%)	95.19	88.31	86.83	81.11	95.37
Valuation Ratios
Enterprise Value (Cr.)	21,622.45	15,593.20	12,669.23	8,751.78	8,705.86
EV/Net Operating Revenue (X)	4.25	6.78	6.50	5.59	7.49
EV/EBITDA (X)	13.95	27.69	28.24	23.91	24.35
MarketCap/Net Operating Revenue (X)	4.19	6.67	6.43	5.32	6.59
Retention Ratios (%)	94.61	87.49	85.96	79.60	94.90
Price/BV (X)	4.31	5.28	4.97	3.81	3.87
Price/Net Operating Revenue	4.19	6.67	6.43	5.32	6.59
Earnings Yield	0.05	0.03	0.03	0.03	0.03